| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/10428194.2013.819577 |
| P698 | PubMed publication ID | 23808814 |
| P50 | author | Yoshinori Ito | Q92911633 |
| P2093 | author name string | Masao Seto | |
| Hiroshi Kimura | |||
| Michio Suzuki | |||
| Kennosuke Karube | |||
| Seiko Iwata | |||
| Kyoko Hirano | |||
| P2860 | cites work | Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type | Q33677463 |
| Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009. | Q37625441 | ||
| Practical management of natural killer/T-cell lymphoma | Q38018224 | ||
| Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma | Q39329997 | ||
| Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses | Q39521104 | ||
| Bortezomib induces apoptosis in T lymphoma cells and natural killer lymphoma cells independent of Epstein-Barr virus infection. | Q39618066 | ||
| Activating mutations in human acute megakaryoblastic leukemia. | Q39945867 | ||
| Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies. | Q42810702 | ||
| EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. | Q44161005 | ||
| Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type. | Q53664277 | ||
| Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia. | Q54522930 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 962-963 | |
| P577 | publication date | 2013-07-29 | |
| P1433 | published in | Leukemia & Lymphoma | Q6534493 |
| P1476 | title | Rare occurrence of JAK3 mutations in natural killer cell neoplasms in Japan | |
| P478 | volume | 55 |
| Q92262684 | Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells |
| Q54342283 | Activated janus kinase 3 expression not by activating mutations identified in natural killer/T-cell lymphoma. |
| Q42827073 | Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells |
| Q58576133 | Aggressive NK-Cell Leukemia |
| Q30275203 | Cutaneous EBV-related lymphoproliferative disorders |
| Q38201143 | Disease-specific mutations in mature lymphoid neoplasms: recent advances |
| Q40717160 | Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma |
| Q40101543 | Frequent BCOR aberrations in extranodal NK/T-Cell lymphoma, nasal type |
| Q36232164 | Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type |
| Q90216134 | Genome profiling revealed the activation of IL2RG/JAK3/STAT5 in peripheral T‑cell lymphoma expressing the ITK‑SYK fusion gene |
| Q64120387 | JAK3/STAT3 oncogenic pathway and PRDM1 expression stratify clinicopathologic features of extranodal NK/T‑cell lymphoma, nasal type |
| Q38597997 | Molecular Pathogenesis of Peripheral T Cell Lymphoma |
| Q64085662 | Molecular pathogenic pathways in extranodal NK/T cell lymphoma |
| Q64087879 | Pathogenesis and biomarkers of natural killer T cell lymphoma (NKTL) |
| Q59354279 | STAT3 is constitutively activated in chronic active Epstein-Barr virus infection and can be a therapeutic target |
| Q60019698 | The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for Translation |
| Q87195954 | [The progress of diagnostic and prognostic molecular markers of lymphoma] |
Search more.